Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: The AleCardio randomized clinical trial / Lincoff, A. Michael; Tardif, Jean Claude; Schwartz, Gregory G.; Nicholls, Stephen J.; Rydén, Lars; Neal, Bruce; Malmberg, Klas; Wedel, Hans; Buse, John B.; Henry, Robert R.; Weichert, Arlette; Cannata, Ruth; Svensson, Anders; Volz, Dietmar; Grobbee, Diederick E.; PERRONE FILARDI, Pasquale. - In: JAMA. - ISSN 0098-7484. - 311:15(2014), pp. 1515-1525. [10.1001/jama.2014.3321]

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: The AleCardio randomized clinical trial

PERRONE FILARDI, PASQUALE
2014

2014
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: The AleCardio randomized clinical trial / Lincoff, A. Michael; Tardif, Jean Claude; Schwartz, Gregory G.; Nicholls, Stephen J.; Rydén, Lars; Neal, Bruce; Malmberg, Klas; Wedel, Hans; Buse, John B.; Henry, Robert R.; Weichert, Arlette; Cannata, Ruth; Svensson, Anders; Volz, Dietmar; Grobbee, Diederick E.; PERRONE FILARDI, Pasquale. - In: JAMA. - ISSN 0098-7484. - 311:15(2014), pp. 1515-1525. [10.1001/jama.2014.3321]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/618676
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 189
  • ???jsp.display-item.citation.isi??? ND
social impact